Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.72 USD
Change Today -0.20 / -1.12%
Volume 848.5K
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

reckitt benckiser-spon adr (RBGLY) Key Developments

Reckitt Benckiser To Sell Medcom

Reckitt Benckiser Group plc (LSE:RB.) plans to sell Medcom-MP LLC.

Reckitt Benckiser Group plc Reports Revenue Results for the First Quarter of 2015; Reaffirms Revenue Guidance for 2015

Reckitt Benckiser Group plc reported revenue results for the first quarter of 2015. For the quarter, the company reported revenues of £2,216 million. The Group is on track to achieve 2015 financial targets of like for like net revenue growth of +4% and a moderate to nice operating margin expansion.

RB Issues Voluntary Recall of Liquid Bottles of MUCINEX® FAST-MAX® Night Time Cold & Flu; MUCINEX® FAST-MAX® Cold & Sinus; MUCINEX® FAST-MAX® Severe Congestion & Cough and MUCINEX® FAST-MAX® Cold, Flu & Sore Throat

Reckitt Benckiser has recalled certain lots of liquid bottles of MUCINEX® FAST-MAX® Night Time Cold & Flu; MUCINEX® FAST-MAX® Cold & Sinus; MUCINEX® FAST-MAX® Severe Congestion & Cough and MUCINEX® FAST-MAX® Cold, Flu & Sore Throat because the over-the-counter medications, which correctly label the product on the front of the bottle and lists all active ingredients, may not have the correct corresponding drug facts label on the back. This recall was due to a confirmed report from a retailer. This mislabeling could cause the consumer to be unaware of side effects and/or risks associated with the ingestion of certain product ingredients which include Acetaminophen, Dextromethorphan, Guaifenesin, Phenylephrine and/or Diphenhydramine. The voluntary recall is being issued nationwide as a precautionary measure to ensure consumers have all relevant facts and warnings for the active ingredients contained in the bottle. Consumers could take a product with undeclared levels of Acetaminophen, Dextromethorphan, Guaifenesin, Phenylephrine and/or Diphenhydramine. Consumers would not be adequately warned of side effects which could potentially lead to health complications requiring urgent medical intervention, particularly in the case of acetaminophen use in people with liver impairment, taking three or more alcoholic drinks or when taking other medicines containing this active ingredient without consulting a doctor. RB is notifying its distributors and customers by direct correspondence. As a precautionary measure, RB is asking consumers to responsibly dispose of any unused product in accordance with the following recommended guidance for drug disposal in household trash: Mix liquid medicines with an unpalatable substance such as kitty litter or used coffee grounds; Place the mixture in a container such as a sealed plastic bag; and Throw the container in household trash.

Reckitt Benckiser Group plc, Q1 2015 Sales/ Trading Statement Call, Apr 24, 2015

Reckitt Benckiser Group plc, Q1 2015 Sales/ Trading Statement Call, Apr 24, 2015

Reckitt Benckiser Group plc Recommends Dividend for the Year Ended December 31, 2014, Payable on May 29, 2015

Reckitt Benckiser Group plc announced that at the annual general meeting to be held on May 7, 2015, will recommend the final dividend of 79 pence per ordinary share for the year ended 31 December 2014 payable on 29 May 2015 to all shareholders on the register at the close of business on 17 April 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RBGLY:US $17.72 USD -0.20

RBGLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Colgate-Palmolive Co $67.68 USD +0.40
Danone SA €64.51 EUR +0.13
EI du Pont de Nemours & Co $74.04 USD +0.84
Mondelez International Inc $38.65 USD +0.28
Unilever PLC 2,875 GBp +9.00
View Industry Companies
 

Industry Analysis

RBGLY

Industry Average

Valuation RBGLY Industry Range
Price/Earnings 24.8x
Price/Sales -- Not Meaningful
Price/Book 5.9x
Price/Cash Flow 12.5x
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RECKITT BENCKISER-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.